Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H

Min Huang, Yanhong Wang, Jingjin Gu, Jing Yang, Karen Noel, Beverly S. Mitchell, Vern L. Schramm, Lee M. Graves

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Immucillin-H (BCX-1777, forodesine) is a transition state analogue and potent inhibitor of PNP that shows promise as a specific agent against activated human T-cells and T-cell leukemias. The immunosuppressive or antileukemic effects of Immucillin-H (ImmH) in cultured cells require co-administration with deoxyguanosine (dGuo) to attain therapeutic levels of intracellular dGTP. In this study we investigated the requirements for sensitivity and resistance to ImmH and dGuo. 3H-ImmH transport assays demonstrated that the equilibrative nucleoside transporters (ENT1 and ENT2) facilitated the uptake of ImmH in human leukemia CCRF-CEM cells whereas 3H-dGuo uptake was primarily dependent upon concentrative nucleoside transporters (CNTs). Analysis of lysates from ImmH-resistant CCRF-CEM-AraC-8D cells demonstrated undetectable deoxycytidine kinase (dCK) activity, suggesting that dCK and not deoxyguanosine kinase (dGK) was the rate-limiting enzyme for phosphorylation of dGuo in these cells. Examination of ImmH cytotoxicity in a hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient cell line CCRF-CEM-AraC-8C, demonstrated enhanced sensitivity to low concentrations of ImmH and dGuo. RT-PCR and sequencing of HGPRT from the HGPRT-deficient CCRF-CEM-AraC-8C cells identified an Exon 8 deletion mutation in this enzyme. Thus these studies show that specific nucleoside transporters are required for ImmH cytotoxicity and predict that ImmH may be more cytotoxic to 6-thioguanine (6-TG) or 6-thiopurine-resistant leukemia cells caused by HGPRT deficiency.

Original languageEnglish (US)
Pages (from-to)1268-1278
Number of pages11
JournalLeukemia Research
Volume32
Issue number8
DOIs
StatePublished - Aug 2008

Fingerprint

T-Cell Leukemia
Deoxyguanosine
Nucleoside Transport Proteins
Hypoxanthine Phosphoribosyltransferase
Deoxycytidine Kinase
deoxyguanosine kinase
forodesine
Leukemia
Lesch-Nyhan Syndrome
Thioguanine
6-Mercaptopurine
Sequence Deletion
Enzymes
Immunosuppressive Agents
Exons
Cultured Cells

Keywords

  • Deoxycytidine kinase
  • Deoxyguanosine
  • Hypoxanthine-guanine phosphoribosyltransferase
  • Immucillin
  • Nucleoside transporters
  • T-cell leukemia

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Huang, M., Wang, Y., Gu, J., Yang, J., Noel, K., Mitchell, B. S., ... Graves, L. M. (2008). Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H. Leukemia Research, 32(8), 1268-1278. https://doi.org/10.1016/j.leukres.2007.12.015

Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H. / Huang, Min; Wang, Yanhong; Gu, Jingjin; Yang, Jing; Noel, Karen; Mitchell, Beverly S.; Schramm, Vern L.; Graves, Lee M.

In: Leukemia Research, Vol. 32, No. 8, 08.2008, p. 1268-1278.

Research output: Contribution to journalArticle

Huang, M, Wang, Y, Gu, J, Yang, J, Noel, K, Mitchell, BS, Schramm, VL & Graves, LM 2008, 'Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H', Leukemia Research, vol. 32, no. 8, pp. 1268-1278. https://doi.org/10.1016/j.leukres.2007.12.015
Huang, Min ; Wang, Yanhong ; Gu, Jingjin ; Yang, Jing ; Noel, Karen ; Mitchell, Beverly S. ; Schramm, Vern L. ; Graves, Lee M. / Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H. In: Leukemia Research. 2008 ; Vol. 32, No. 8. pp. 1268-1278.
@article{438ebd55e43e4bb79e7c248f1537b2a1,
title = "Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H",
abstract = "Immucillin-H (BCX-1777, forodesine) is a transition state analogue and potent inhibitor of PNP that shows promise as a specific agent against activated human T-cells and T-cell leukemias. The immunosuppressive or antileukemic effects of Immucillin-H (ImmH) in cultured cells require co-administration with deoxyguanosine (dGuo) to attain therapeutic levels of intracellular dGTP. In this study we investigated the requirements for sensitivity and resistance to ImmH and dGuo. 3H-ImmH transport assays demonstrated that the equilibrative nucleoside transporters (ENT1 and ENT2) facilitated the uptake of ImmH in human leukemia CCRF-CEM cells whereas 3H-dGuo uptake was primarily dependent upon concentrative nucleoside transporters (CNTs). Analysis of lysates from ImmH-resistant CCRF-CEM-AraC-8D cells demonstrated undetectable deoxycytidine kinase (dCK) activity, suggesting that dCK and not deoxyguanosine kinase (dGK) was the rate-limiting enzyme for phosphorylation of dGuo in these cells. Examination of ImmH cytotoxicity in a hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient cell line CCRF-CEM-AraC-8C, demonstrated enhanced sensitivity to low concentrations of ImmH and dGuo. RT-PCR and sequencing of HGPRT from the HGPRT-deficient CCRF-CEM-AraC-8C cells identified an Exon 8 deletion mutation in this enzyme. Thus these studies show that specific nucleoside transporters are required for ImmH cytotoxicity and predict that ImmH may be more cytotoxic to 6-thioguanine (6-TG) or 6-thiopurine-resistant leukemia cells caused by HGPRT deficiency.",
keywords = "Deoxycytidine kinase, Deoxyguanosine, Hypoxanthine-guanine phosphoribosyltransferase, Immucillin, Nucleoside transporters, T-cell leukemia",
author = "Min Huang and Yanhong Wang and Jingjin Gu and Jing Yang and Karen Noel and Mitchell, {Beverly S.} and Schramm, {Vern L.} and Graves, {Lee M.}",
year = "2008",
month = "8",
doi = "10.1016/j.leukres.2007.12.015",
language = "English (US)",
volume = "32",
pages = "1268--1278",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H

AU - Huang, Min

AU - Wang, Yanhong

AU - Gu, Jingjin

AU - Yang, Jing

AU - Noel, Karen

AU - Mitchell, Beverly S.

AU - Schramm, Vern L.

AU - Graves, Lee M.

PY - 2008/8

Y1 - 2008/8

N2 - Immucillin-H (BCX-1777, forodesine) is a transition state analogue and potent inhibitor of PNP that shows promise as a specific agent against activated human T-cells and T-cell leukemias. The immunosuppressive or antileukemic effects of Immucillin-H (ImmH) in cultured cells require co-administration with deoxyguanosine (dGuo) to attain therapeutic levels of intracellular dGTP. In this study we investigated the requirements for sensitivity and resistance to ImmH and dGuo. 3H-ImmH transport assays demonstrated that the equilibrative nucleoside transporters (ENT1 and ENT2) facilitated the uptake of ImmH in human leukemia CCRF-CEM cells whereas 3H-dGuo uptake was primarily dependent upon concentrative nucleoside transporters (CNTs). Analysis of lysates from ImmH-resistant CCRF-CEM-AraC-8D cells demonstrated undetectable deoxycytidine kinase (dCK) activity, suggesting that dCK and not deoxyguanosine kinase (dGK) was the rate-limiting enzyme for phosphorylation of dGuo in these cells. Examination of ImmH cytotoxicity in a hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient cell line CCRF-CEM-AraC-8C, demonstrated enhanced sensitivity to low concentrations of ImmH and dGuo. RT-PCR and sequencing of HGPRT from the HGPRT-deficient CCRF-CEM-AraC-8C cells identified an Exon 8 deletion mutation in this enzyme. Thus these studies show that specific nucleoside transporters are required for ImmH cytotoxicity and predict that ImmH may be more cytotoxic to 6-thioguanine (6-TG) or 6-thiopurine-resistant leukemia cells caused by HGPRT deficiency.

AB - Immucillin-H (BCX-1777, forodesine) is a transition state analogue and potent inhibitor of PNP that shows promise as a specific agent against activated human T-cells and T-cell leukemias. The immunosuppressive or antileukemic effects of Immucillin-H (ImmH) in cultured cells require co-administration with deoxyguanosine (dGuo) to attain therapeutic levels of intracellular dGTP. In this study we investigated the requirements for sensitivity and resistance to ImmH and dGuo. 3H-ImmH transport assays demonstrated that the equilibrative nucleoside transporters (ENT1 and ENT2) facilitated the uptake of ImmH in human leukemia CCRF-CEM cells whereas 3H-dGuo uptake was primarily dependent upon concentrative nucleoside transporters (CNTs). Analysis of lysates from ImmH-resistant CCRF-CEM-AraC-8D cells demonstrated undetectable deoxycytidine kinase (dCK) activity, suggesting that dCK and not deoxyguanosine kinase (dGK) was the rate-limiting enzyme for phosphorylation of dGuo in these cells. Examination of ImmH cytotoxicity in a hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient cell line CCRF-CEM-AraC-8C, demonstrated enhanced sensitivity to low concentrations of ImmH and dGuo. RT-PCR and sequencing of HGPRT from the HGPRT-deficient CCRF-CEM-AraC-8C cells identified an Exon 8 deletion mutation in this enzyme. Thus these studies show that specific nucleoside transporters are required for ImmH cytotoxicity and predict that ImmH may be more cytotoxic to 6-thioguanine (6-TG) or 6-thiopurine-resistant leukemia cells caused by HGPRT deficiency.

KW - Deoxycytidine kinase

KW - Deoxyguanosine

KW - Hypoxanthine-guanine phosphoribosyltransferase

KW - Immucillin

KW - Nucleoside transporters

KW - T-cell leukemia

UR - http://www.scopus.com/inward/record.url?scp=42749084016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42749084016&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2007.12.015

DO - 10.1016/j.leukres.2007.12.015

M3 - Article

C2 - 18279955

AN - SCOPUS:42749084016

VL - 32

SP - 1268

EP - 1278

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 8

ER -